These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 30052304)

  • 21. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary Arterial Elastance and INTERMACS-Defined Right Heart Failure Following Left Ventricular Assist Device.
    Muslem R; Ong CS; Tomashitis B; Schultz J; Ramu B; Craig ML; Van Bakel AB; Gilotra NA; Sharma K; Hsu S; Whitman GJ; Leary PJ; Cogswell R; Lozonschi L; Houston BA; Zijlstra F; Caliskan K; Bogers AJJC; Tedford RJ
    Circ Heart Fail; 2019 Aug; 12(8):e005923. PubMed ID: 31401840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HeartMate left ventricular assist device as bridge to heart transplantation.
    Koul B; Solem JO; Steen S; Casimir-Ahn H; Granfeldt H; Lönn UJ
    Ann Thorac Surg; 1998 Jun; 65(6):1625-30. PubMed ID: 9647070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial.
    Mehra MR; Goldstein DJ; Cleveland JC; Cowger JA; Hall S; Salerno CT; Naka Y; Horstmanshof D; Chuang J; Wang A; Uriel N
    JAMA; 2022 Sep; 328(12):1233-1242. PubMed ID: 36074476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival after left ventricular assist device with and without temporary right ventricular support.
    Lazar JF; Swartz MF; Schiralli MP; Schneider M; Pisula B; Hallinan W; Hicks GL; Massey HT
    Ann Thorac Surg; 2013 Dec; 96(6):2155-9. PubMed ID: 24035303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: a Japanese multicenter study using J-MACS.
    Saito S; Yamazaki K; Nishinaka T; Ichihara Y; Ono M; Kyo S; Nishimura T; Nakatani T; Toda K; Sawa Y; Tominaga R; Tanoue T; Saiki Y; Matsui Y; Takemura T; Niinami H; Matsumiya G;
    J Heart Lung Transplant; 2014 Jun; 33(6):599-608. PubMed ID: 24746637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First experiences with HeartMate 3 follow-up and adverse events.
    Hanke JS; Dogan G; Rojas SV; Zoch A; Feldmann C; Deniz E; Avsar M; Warnecke G; Haverich A; Schmitto JD
    J Thorac Cardiovasc Surg; 2017 Jul; 154(1):173-178. PubMed ID: 28268010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Six-month outcomes after treatment of advanced heart failure with a full magnetically levitated continuous flow left ventricular assist device: report from the ELEVATE registry.
    Gustafsson F; Shaw S; Lavee J; Saeed D; Pya Y; Krabatsch T; Schmitto J; Morshuis M; Chuang J; Damme L; Zimpfer D; Garbade J
    Eur Heart J; 2018 Oct; 39(37):3454-3460. PubMed ID: 30165521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy.
    Park SJ; Milano CA; Tatooles AJ; Rogers JG; Adamson RM; Steidley DE; Ewald GA; Sundareswaran KS; Farrar DJ; Slaughter MS;
    Circ Heart Fail; 2012 Mar; 5(2):241-8. PubMed ID: 22282104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study.
    Colombo PC; Mehra MR; Goldstein DJ; Estep JD; Salerno C; Jorde UP; Cowger JA; Cleveland JC; Uriel N; Sayer G; Skipper ER; Downey FX; Ono M; Hooker R; Anyanwu AC; Givertz MM; Mahr C; Topuria I; Somo SI; Crandall DL; Horstmanshof DA
    Circulation; 2019 Jan; 139(2):155-168. PubMed ID: 30586698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Decade of Experience With Continuous-Flow Left Ventricular Assist Devices.
    John R; Holley CT; Eckman P; Roy SS; Cogswell R; Harvey L; Shumway S; Liao K
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):363-375. PubMed ID: 28043445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fully magnetically centrifugal left ventricular assist device and long-term outcomes: the ELEVATE registry.
    Schmitto JD; Shaw S; Garbade J; Gustafsson F; Morshuis M; Zimpfer D; Lavee J; Pya Y; Berchtold-Herz M; Wang A; Gazzola C; Potapov E; Saeed D
    Eur Heart J; 2024 Feb; 45(8):613-625. PubMed ID: 38036414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term biventricular HeartWare ventricular assist device support--Case series of right atrial and right ventricular implantation outcomes.
    Shehab S; Macdonald PS; Keogh AM; Kotlyar E; Jabbour A; Robson D; Newton PJ; Rao S; Wang L; Allida S; Connellan M; Granger E; Dhital K; Spratt P; Jansz PC; Hayward CS
    J Heart Lung Transplant; 2016 Apr; 35(4):466-73. PubMed ID: 26849954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmarket Experience With HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes From the ELEVATE Registry.
    Garbade J; Gustafsson F; Shaw S; Lavee J; Saeed D; Pya Y; Krabatsch T; Schmitto JD; Morshuis M; Chuang J; Zimpfer D
    Ann Thorac Surg; 2019 Jan; 107(1):33-39. PubMed ID: 30291831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction.
    Müller D; Remppis A; Schauerte P; Schmidt-Schweda S; Burkhoff D; Rousso B; Gutterman D; Senges J; Hindricks G; Kuck KH
    Clin Res Cardiol; 2017 Nov; 106(11):893-904. PubMed ID: 28685207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous-Flow Left Ventricular Assist Device Survival Improves With Multidisciplinary Approach.
    Jorde UP; Shah AM; Sims DB; Madan S; Siddiqi N; Luke A; Saeed O; Patel SR; Murthy S; Shin J; Oviedo J; Watts S; Jakobleff W; Forest S; Vukelic S; Belov D; Puius Y; Minamoto G; Muggia V; Carlese A; Leung S; Rahmanian M; Leff J; Goldstein D
    Ann Thorac Surg; 2019 Aug; 108(2):508-516. PubMed ID: 30853587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.